Jain, Nitin <br/><br/>
Selecting Frontline Therapy for CLL in 2018.  [electronic resource] 

 -  Hematology. American Society of Hematology. Education Program  11 2018 
 - 242-247 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1520-4383 
<br/><br/><label>Standard No.: </label>10.1182/asheducation-2018.1.242  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Age Factors<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chlorambucil--therapeutic use<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 17<br/>Clinical Trials, Phase III as Topic<br/>Cyclophosphamide--therapeutic use<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Piperidines<br/>Pyrazoles--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Rituximab--therapeutic use<br/>Smith-Magenis Syndrome<br/>Vidarabine--analogs & derivatives